Literature DB >> 20605716

Biotransformation of ginsenoside Rb1 to ginsenoside Rd by highly substrate-tolerant Paecilomyces bainier 229-7.

Li Ye1, Chao-Qun Zhou, Wei Zhou, Pei Zhou, Dao-Feng Chen, Xiao-Hui Liu, Xun-Long Shi, Mei-Qing Feng.   

Abstract

Paecilomyces bainier 229-7 was obtained after UV irradiation for 8 min in the presence of 0.4% LiCl and selection on potato dextrose media containing 30 mg/mL saponin from Panax notoginseng leaves (SPNL). The mutant produces ginsenoside Rd from ginsenoside Rb1 with a bioconversion rate as high as 94.9% under optimized culture conditions in shake flasks when supplied with 20 mg/mL of SPNL. Scale-up in 10-L fermenter resulted in an 89% bioconversion rate. Ginsenoside Rd was purified from the culture medium by a macroporous resin with a chromatographic purity of 92.6%. These results suggest that P. bainier 229-7 could be useful for the preparation of ginsenoside Rd in the pharmaceutical industry.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20605716     DOI: 10.1016/j.biortech.2010.04.102

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  16 in total

1.  Fermentation of ginseng extracts by Penicillium simplicissimum GS33 and anti-ovarian cancer activity of fermented products.

Authors:  Yu Fu; Zhenhao Yin; Lunpeng Wu; Chengri Yin
Journal:  World J Microbiol Biotechnol       Date:  2014-03       Impact factor: 3.312

2.  Effective bioconversion of sophoricoside to genistein from Fructus sophorae using immobilized Aspergillus niger and Yeast.

Authors:  Chen Feng; Shuang Jin; Xin-Xin Xia; Yue Guan; Meng Luo; Yuan-Gang Zu; Yu-Jie Fu
Journal:  World J Microbiol Biotechnol       Date:  2014-11-13       Impact factor: 3.312

3.  Effects of external calcium on the biotransformation of ginsenoside Rb1 to ginsenoside Rd by Paecilomyces bainier 229-7.

Authors:  Li Ye; Chunyan Zhang; Jiyang Li; Xunlong Shi; Meiqing Feng
Journal:  World J Microbiol Biotechnol       Date:  2011-09-16       Impact factor: 3.312

4.  Bioconversion, health benefits, and application of ginseng and red ginseng in dairy products.

Authors:  Jieun Jung; Na-Kyoung Lee; Hyun-Dong Paik
Journal:  Food Sci Biotechnol       Date:  2017-08-17       Impact factor: 2.391

5.  Identification and characterization of the Rhizobium sp. strain GIN611 glycoside oxidoreductase resulting in the deglycosylation of ginsenosides.

Authors:  Eun-Mi Kim; Juhan Kim; Joo-Hyun Seo; Jun-Seong Park; Duck-Hee Kim; Byung-Gee Kim
Journal:  Appl Environ Microbiol       Date:  2011-10-21       Impact factor: 4.792

6.  Enhancement of microbial hydroxylation of 13-ethyl-gon-4-ene-3,17-dione by Metarhizium anisopliae using nano-liposome technique.

Authors:  Meiqing Feng; Ziwei Liao; Lei Han; Jiyang Li; Li Ye
Journal:  J Ind Microbiol Biotechnol       Date:  2014-02-19       Impact factor: 3.346

7.  Investigation on the mechanisms for biotransformation of saponins to diosgenin.

Authors:  Yuling Zhu; Hancan Zhu; Muqing Qiu; Tingting Zhu; Jinren Ni
Journal:  World J Microbiol Biotechnol       Date:  2013-07-17       Impact factor: 3.312

8.  Diversity and Ginsenoside Biotransformation Potential of Cultivable Endophytic Fungi Associated With Panax bipinnatifidus var. bipinnatifidus in Qinling Mountains, China.

Authors:  Chao An; Saijian Ma; Xinwei Shi; Chen Liu; Hao Ding; Wenjiao Xue
Journal:  Front Pharmacol       Date:  2022-04-04       Impact factor: 5.988

9.  Bioconversion of ginsenosides in the american ginseng ( xī yáng shēn) extraction residue by fermentation with lingzhi ( líng zhī, ganoderma lucidum).

Authors:  Bo Yang Hsu; Chia Hui Chen; Ting Jang Lu; Lucy Sun Hwang
Journal:  J Tradit Complement Med       Date:  2013-04

10.  Enzymatic Biotransformation of Ginsenoside Rb1 and Gypenoside XVII into Ginsenosides Rd and F2 by Recombinant β-glucosidase from Flavobacterium johnsoniae.

Authors:  Hao Hong; Chang-Hao Cui; Jin-Kwang Kim; Feng-Xie Jin; Sun-Chang Kim; Wan-Taek Im
Journal:  J Ginseng Res       Date:  2012-10       Impact factor: 6.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.